STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide.

Autor:	Abdelhamid AM; Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt., Saber S; Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt., Hamad RS; Biological Sciences Department, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.; Central Laboratory, Theodor Bilharz Research Institute, Giza, Egypt., Abdel-Reheim MA; Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt., Ellethy AT; Department of Oral and Medical Basic Sciences, Biochemistry Division, College of Dentistry, Qassim University, Buraidah, Saudi Arabia., Amer MM; Department of Anatomy, College of Medicine, Qassim University, Buraidah, Saudi Arabia.; Department of Anatomy and Embryology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Abdel-Hamed MR; Department of Anatomy, College of Medicine, Qassim University, Buraidah, Saudi Arabia.; Department of Anatomy and Embryology, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Mohamed EA; Department of Anatomy, College of Medicine, Qassim University, Buraidah, Saudi Arabia.; Department of Anatomy, Faculty of Medicine, Cairo University, Cairo, Egypt., Ahmed SS; Department of Microbiology and Immunology, College of Medicine, Qassim University, Buraidah, Saudi Arabia., Elsisi HA; Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraidah, Saudi Arabia.; Department of Clinical Pharmacology, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Khodeir MM; Department of Pathology, College of Medicine, Qassim University, Buraidah, Saudi Arabia.; Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt., Alkhamiss AS; Department of Pathology, College of Medicine, Qassim University, Buraidah, Saudi Arabia., A AA; Department of Pathology, College of Medicine, Qassim University, Buraidah, Saudi Arabia., Abu Elgasim MAE; Department of Family and Community Medicine, College of Medicine, Qassim University, Buraidah, Saudi Arabia., Almansour ZH; Biological Sciences Department, College of Science, King Faisal University, Hofuf, Saudi Arabia., Elesawy BH; Department of Pathology, College of Medicine, Taif University, Taif, Saudi Arabia.; Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Elmorsy EA; Department of Pharmacology and Therapeutics, College of Medicine, Qassim University, Buraidah, Saudi Arabia.
Jazyk:	angličtina
Zdroj:	Frontiers in pharmacology [Front Pharmacol] 2024 Sep 04; Vol. 15, pp. 1454829. Date of Electronic Publication: 2024 Sep 04 (Print Publication: 2024).
DOI:	10.3389/fphar.2024.1454829
Abstrakt:	Introduction: Liver fibrosis is a significant global health burden that lacks effective therapies. It can progress to cirrhosis and hepatocellular carcinoma (HCC). Aberrant hedgehog pathway activation is a key driver of fibrogenesis and cancer, making hedgehog inhibitors potential antifibrotic and anticancer agents. Methods: We evaluated simvastatin and STA-9090, alone and combined, in rats fed a high-fat diet (HFD) and exposed to diethylnitrosamine and thioacetamide (DENA/TAA). Simvastatin inhibits HMG-CoA reductase, depleting cellular cholesterol required for Sonic hedgehog (Shh) modification and signaling. STA-9090 directly inhibits HSP90 chaperone interactions essential for Shh function. We hypothesized combining these drugs may provide liver protective effects through complementary targeting of the hedgehog pathway. Endpoints assessed included liver function tests, oxidative stress markers, histopathology, extracellular matrix proteins, inflammatory cytokines, and hedgehog signaling components. Results: HFD and DENA/TAA caused aberrant hedgehog activation, contributing to fibrotic alterations with elevated liver enzymes, oxidative stress, dyslipidemia, inflammation, and collagen deposition. Monotherapies with simvastatin or STA-9090 improved these parameters, while the combination treatment provided further enhancements, including improved survival, near-normal liver histology, and compelling hedgehog pathway suppression. Discussion: Our findings demonstrate the enhanced protective potential of combined HMG CoA reductase and HSP90 inhibition in rats fed a HFD and exposed to DENA and TAA. This preclinical study could help translate hedgehog-targeted therapies to clinical evaluation for treating this major unmet need. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Abdelhamid, Saber, Hamad, Abdel-Reheim, Ellethy, Amer, Abdel-Hamed, Mohamed, Ahmed, Elsisi, Khodeir, Alkhamiss, A., Abu Elgasim, Almansour, Elesawy and Elmorsy.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu